Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine Coadministered With Two Attenuated Vaccines
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05952505 |
|
Recruitment Status :
Not yet recruiting
First Posted : July 19, 2023
Last Update Posted : July 19, 2023
|
Sponsor:
Shanghai Municipal Center for Disease Control and Prevention
Collaborator:
China National Biotec Group Company Limited
Information provided by (Responsible Party):
HUANG Zhuoying, Shanghai Municipal Center for Disease Control and Prevention
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Not yet recruiting |
|---|---|
| Estimated Primary Completion Date : | December 2023 |
| Estimated Study Completion Date : | December 2024 |